Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs reteplase vs taurolock for prevention of thrombosis in hemodialysis catheters
IRCT20220103053614N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin, reteplase and taurolidine in catheter-related thrombosis (CRT) (3 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoint: Catheter thrombosis incidence. Started Nov 2021; status: completed.
02
Drugs
heparinreteplasetaurolidine
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20220103053614N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220103053614N1.